-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that as competition between the two pharmaceutical giants continues to escalate, Novo Nordisk (NVO.US) has filed a lawsuit in the US federal court, accusing LLY.US (LLY.US) of misleading advertisements for its best-selling diet drug Zepbound and the diabetes injectable drug Mounjaro.

Zhitongcaijing·07/21/2026 12:49:12
Listen to the news
The Zhitong Finance App learned that as competition between the two pharmaceutical giants continues to escalate, Novo Nordisk (NVO.US) has filed a lawsuit in the US federal court, accusing LLY.US (LLY.US) of misleading advertisements for its best-selling diet drug Zepbound and the diabetes injectable drug Mounjaro.